Page last updated: 2024-08-18

pyrroles and Thrombopenia

pyrroles has been researched along with Thrombopenia in 44 studies

Research

Studies (44)

TimeframeStudies, this research(%)All Research%
pre-19901 (2.27)18.7374
1990's1 (2.27)18.2507
2000's3 (6.82)29.6817
2010's37 (84.09)24.3611
2020's2 (4.55)2.80

Authors

AuthorsStudies
Fu, Q; Jiang, X; Jing, Y; Peng, H; Rexiti, K; Tao, S; Wei, X; Xiong, F1
Kadoba, K; Mukoyama, H; Murabe, H; Nishimura, K; Saito, R; Waki, D; Yokota, T1
Broder, MS; Chang, E; Neary, MP; Reddy, SR1
Blackwood, EM; Cousin, S; DuPree, K; Epler, J; Hamilton, E; Hollebecque, A; Infante, JR; Italiano, A; Lauchle, JO; LoRusso, PM; Lu, X; Mahrus, S; Moein, A; Moore, KN; Murray, ER; Peale, FV; Postel-Vinay, S; Schutzman, JL; Shapiro, GI; Soria, JC; Tagen, M; Tolaney, S; Toulmonde, M1
Aki, R; Ito, T; Matsushita, Y; Miyake, H; Motoyama, D; Otsuka, A; Sugiyama, T; Tamura, K1
Cai, W; Chen, YH; Dong, BJ; Huang, JW; Huang, YR; Kong, W; Li, MY; Xue, W; Yuan, YC; Zhang, J; Zhou, LX1
Adashek, JJ; Bergerot, PG; Boyd, T; Carret, AS; Chhabra, S; Forero-Torres, A; Gartner, EM; Hoimes, CJ; Li, H; Morris, JC; Pal, SK; Smith, DC; Thompson, JA; Vogelzang, NJ; Yu, X1
Funakoshi, T; Galsky, MD; Latif, A1
Cataruozolo, PE; Cesari, R; Collier, M; Cortés, J; Curigliano, G; Elias, A; Goldhirsch, A; Huang, X; Kern, KA; Khosravan, R; Pivot, X1
Casado Herráez, A; Currás Freixes, M; Díaz Pérez, JÁ; Ochagavía Cámara, S1
Bekaii-Saab, T; Clinton, SK; Grever, MR; Kraut, EH; Martin, LK; Monk, P; Serna, D1
Battista, K; Buckstein, R; Howson-Jan, K; Ivy, SP; Kovacs, MJ; Oza, AM; Schuh, AC; Storring, JM; Wang, ES; Wang, L; Wells, RA; Xenocostas, A; Yee, KW1
Arellano, ML; Berger, M; Borthakur, G; Luer, J; Raza, A1
Bono, P; Donskov, F; Joensuu, H; Peltola, K; Rautiola, J1
Chen, Y; Hong, S; Luo, S; Tan, M; Wang, S; Zhang, L1
Chi, Z; Cui, C; Dai, J; Guo, J; Kong, Y; Li, S; Lian, B; Mao, L; Sheng, X; Si, L; Tang, H; Wang, X; Yan, X1
Basso, U; Bonetti, A; Bracarda, S; Calabrò, F; Capaccetti, B; Cartenì, G; Ciuffreda, L; Fea, E; Ferrari, V; Fly, K; Gasparini, G; Gasparro, D; Hariharan, S; Labianca, R; Lo Re, G; Masini, C; Porta, C; Ruggeri, EM; Sternberg, CN; Tassinari, D; Zhang, K1
Fujii, Y; Ishiwata, Y; Kihara, K; Nagata, M; Saito, K; Takahashi, H; Takahashi, Y; Yasuhara, M1
Houzawa, H; Komatsu, Y; Nishida, T; Ohki, E; Togo, K; Toyoshima, Y; Ueda, E; Ueno, N; Yoshida, A1
Enokida, H; Fujisawa, M; Fukasawa, S; Fukunaga, K; Hara, I; Hashine, K; Hongo, F; Inoue, T; Kato, Y; Kitamura, H; Kubo, M; Low, SK; Matsuda, K; Matsuyama, H; Miki, T; Mushiroda, T; Nakanishi, H; Nishimura, K; Takahashi, A; Tanaka, T; Tatsugami, K; Tomita, Y; Uemura, H1
Azumi, M; Hashizume, K; Hori, J; Iwata, T; Kakizaki, H; Kita, M; Kobayashi, S; Matsumoto, S; Okazaki, S; Watanabe, M1
Bergman, PJ; Merrick, CH; Pierro, J; Regan, RC; Schleis, SE; Siedlecki, CT; Sones, EA; Wright, ZM1
Arai, Y; Ito, A; Kawasaki, Y; Kikuchi, M; Mano, N; Takasaki, S; Yamaguchi, H1
Baggstrom, MQ; Baker, S; Crawford, JA; Edelman, MJ; Feliciano, J; Gu, L; Hahn, O; Novotny, P; Socinski, MA; Stinchcombe, TE; Vokes, EE; Wang, XF1
Beniak, J; Kakalejcik, M; Reckova, M1
Curiel, RE; Motzer, RJ; Patel, PH; Senico, PL1
Fayyad, R; Figlin, RA; Hariharan, S; Hudes, G; Kempin, S; Motzer, RJ; Schwartz, LH; Wilding, G1
Andreiuolo, F; Bobos, M; Calderaro, J; Fountzilas, G; Fragkoulidi, A; Kalogera-Fountzila, A; Marselos, M; Nikolaidou, M1
Aparicio, LM; Calvo, OF; López, MR; Vázquez, DD1
Ahn, H; Ahn, JH; Hong, B; Hong, JH; Kim, CS; Kim, JE; Lee, DH; Lee, JL; Lee, JS; Na, S; Song, C; Yoo, C1
Boven, E; Eechoute, K; Gelderblom, H; Guchelaar, HJ; Haanen, JB; Mathijssen, RH; Reyners, AK; van der Veldt, AA; van Erp, NP; Wessels, JA1
Al-Tourah, AJ; Buckstein, R; Chua, N; Crump, M; Eisenhauer, EA; Foo, AH; Ivy, SP; Kuruvilla, J; Lee, C; Macdonald, DA; Walsh, W1
Greil, R; Grundbichler, M; Kappacher, A; Mlineritsch, B; Moik, M; Ressler, S; Rosenlechner, S1
Brown, A; Ginsberg, MS; James, L; Juergens, R; Kris, MG; Krug, LM; Markus, S; Paik, PK; Pietanza, MC; Rizvi, NA; Rudin, CM; Subzwari, S; Takebe, N; Travis, W; Tyson, L1
Antón-Aparicio, LM; Cassinello, J; Castellano, D; Esteban, E; González-Larriba, JL; Grande, E; Sepúlveda, J1
Ahn, JB; Bang, YJ; Chung, HC; Hong, MH; Jeung, HC; Kim, HS; Kim, K; Koh, Y; Lee, SH; Rha, SY; Shin, SJ1
Ahn, H; Ahn, JH; Ahn, S; Ahn, Y; Hong, JH; Kim, CS; Kim, TW; Lee, JL; Park, I; Park, K; Park, S; Song, C1
Camidge, DR; Chan, E; Chow Maneval, E; Diab, S; Eckhardt, SG; Khosravan, R; Leong, S; Lin, X; Lockhart, AC; Messersmith, WA; Spratlin, J1
Albersen, A; Hamberg, P; Njo, T; Porcelijn, L; Schilders, J; Zuetenhorst, H1
Brickman, MJ; Citrin, DL; Dees, EC; Healey, P; Kern, KA; Li, S; Myers, SD; Paolini, J; Wang, Z; Yardley, DA1
Han, JH; Han, JY; Kim, HJ; Kim, HT; Kim, HY; Kwak, MH; Lee, JS; Lee, YJ; Lim, KY; Yun, T1
Bondarenko, I; Carrato, A; Christensen, JG; De la Cruz, JA; Jonker, DJ; Korytowsky, B; Lechuga, MJ; Lim, R; Lin, X; Roman, L; Shparyk, Y; Staszewska-Skurczynska, M; Sun, Y; Swieboda-Sadlej, A; Tursi, JM; Van Cutsem, E; Williams, JA1
Lockhart, JM1
Conde, E; Duvós, E; González-Ponte, ML; González-Ruiz, M; Gutiérrez-Iñiguez, MA; Olalla, JI1

Reviews

3 review(s) available for pyrroles and Thrombopenia

ArticleYear
Hematologic toxicities of sunitinib in patients with gastrointestinal stromal tumors: a systematic review and meta-analysis.
    International journal of colorectal disease, 2022, Volume: 37, Issue:7

    Topics: Anemia; Antineoplastic Agents; Gastrointestinal Stromal Tumors; Humans; Neutropenia; Pyrroles; Sunitinib; Thrombocytopenia

2022
Risk of hematologic toxicities in cancer patients treated with sunitinib: a systematic review and meta-analysis.
    Cancer treatment reviews, 2013, Volume: 39, Issue:7

    Topics: Anemia; Angiogenesis Inhibitors; Antineoplastic Agents; Clinical Trials as Topic; Hematologic Diseases; Humans; Incidence; Indoles; Neoplasms; Neutropenia; Publication Bias; Pyrroles; Risk; Sunitinib; Thrombocytopenia

2013
Efficacy and safety of angiogenesis inhibitors in advanced non-small cell lung cancer: a systematic review and meta-analysis.
    Journal of cancer research and clinical oncology, 2015, Volume: 141, Issue:5

    Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bevacizumab; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Hemorrhage; Humans; Indazoles; Indoles; Lung Neoplasms; Niacinamide; Odds Ratio; Phenylurea Compounds; Piperidines; Pyrimidines; Pyrroles; Quinazolines; Ramucirumab; Randomized Controlled Trials as Topic; Receptors, Vascular Endothelial Growth Factor; Signal Transduction; Sorafenib; Sulfonamides; Sunitinib; Thrombocytopenia; Treatment Outcome; Vascular Endothelial Growth Factor A

2015

Trials

21 trial(s) available for pyrroles and Thrombopenia

ArticleYear
Phase I study of the checkpoint kinase 1 inhibitor GDC-0575 in combination with gemcitabine in patients with refractory solid tumors.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2018, 05-01, Volume: 29, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Checkpoint Kinase 1; Deoxycytidine; Dose-Response Relationship, Drug; Drug Interactions; Fatigue; Female; Gemcitabine; Half-Life; Humans; Male; Maximum Tolerated Dose; Middle Aged; Nausea; Neoplasms; Neutropenia; Piperidines; Protein Kinase Inhibitors; Pyridines; Pyrroles; Thrombocytopenia; Treatment Outcome

2018
A phase 1 trial of SGN-CD70A in patients with CD70-positive, metastatic renal cell carcinoma.
    Cancer, 2019, 04-01, Volume: 125, Issue:7

    Topics: Aged; Anemia; Benzodiazepines; Carcinoma, Renal Cell; CD27 Ligand; Edema; Fatigue; Female; Humans; Immunoconjugates; Kidney Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Pyrroles; Thrombocytopenia

2019
Randomized phase II study of sunitinib versus standard of care for patients with previously treated advanced triple-negative breast cancer.
    Breast (Edinburgh, Scotland), 2013, Volume: 22, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Anthracyclines; Antineoplastic Agents; Capecitabine; Chemotherapy, Adjuvant; Deoxycytidine; Disease-Free Survival; Docetaxel; Fatigue; Female; Fluorouracil; Gemcitabine; Hand-Foot Syndrome; Humans; Indoles; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neutropenia; Paclitaxel; Pyrroles; Sunitinib; Survival Rate; Taxoids; Thrombocytopenia; Triple Negative Breast Neoplasms

2013
A phase I dose escalation and pharmacodynamic study of SU5416 (semaxanib) combined with weekly cisplatin and irinotecan in patients with advanced solid tumors.
    Onkologie, 2013, Volume: 36, Issue:11

    Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Chemotherapy-Induced Febrile Neutropenia; Cisplatin; Dose-Response Relationship, Drug; Female; Humans; Indoles; Irinotecan; Male; Middle Aged; Nausea; Neoplasms; Pyrroles; Thrombocytopenia; Treatment Outcome

2013
Sunitinib malate in patients with intermediate-2 or high-risk myelodysplastic syndrome or chronic myelomonocytic leukemia.
    Leukemia & lymphoma, 2014, Volume: 55, Issue:11

    Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Diarrhea; Drug Administration Schedule; Fatigue; Female; Humans; Indoles; Kaplan-Meier Estimate; Leukemia, Myelomonocytic, Chronic; Male; Middle Aged; Myelodysplastic Syndromes; Pyrroles; Remission Induction; Sunitinib; Thrombocytopenia; Treatment Outcome

2014
A phase II, multicenter, open-label study of obatoclax mesylate in patients with previously untreated myelodysplastic syndromes with anemia or thrombocytopenia.
    Clinical lymphoma, myeloma & leukemia, 2014, Volume: 14, Issue:6

    Topics: Aged; Aged, 80 and over; Anemia; Antineoplastic Agents; Disease Progression; Female; Humans; Indoles; Male; Middle Aged; Myelodysplastic Syndromes; Proto-Oncogene Proteins c-bcl-2; Pyrroles; Thrombocytopenia; Treatment Outcome

2014
Safety and efficacy of sunitinib in patients from Italy with metastatic renal cell carcinoma: final results from an expanded-access trial.
    Oncology, 2015, Volume: 88, Issue:5

    Topics: Adult; Aged; Anemia; Antineoplastic Agents; Asthenia; Carcinoma, Renal Cell; Compassionate Use Trials; Diarrhea; Disease-Free Survival; Drug Administration Schedule; Dysgeusia; Female; Follow-Up Studies; Humans; Hypertension; Incidence; Indoles; Italy; Kaplan-Meier Estimate; Kidney Neoplasms; Leukopenia; Male; Middle Aged; Neutropenia; Pyrroles; Stomatitis; Sunitinib; Thrombocytopenia; Treatment Outcome

2015
Safety, efficacy and prognostic analyses of sunitinib in the post-marketing surveillance study of Japanese patients with gastrointestinal stromal tumor.
    Japanese journal of clinical oncology, 2015, Volume: 45, Issue:11

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Asian People; Disease-Free Survival; Female; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Hand-Foot Syndrome; Humans; Incidence; Indoles; Japan; Male; Middle Aged; Neutropenia; Prognosis; Proportional Hazards Models; Pyrroles; Severity of Illness Index; Sunitinib; Thrombocytopenia; Treatment Outcome

2015
Maintenance Sunitinib following Initial Platinum-Based Combination Chemotherapy in Advanced-Stage IIIB/IV Non-Small Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study-CALGB 30607 (Alliance).
    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2017, Volume: 12, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Double-Blind Method; Drug Eruptions; Fatigue; Female; Humans; Hypertension; Indoles; Intention to Treat Analysis; Lung Neoplasms; Maintenance Chemotherapy; Male; Middle Aged; Mucositis; Neoplasm Staging; Neutropenia; Platinum Compounds; Pyrroles; Quality of Life; Sunitinib; Survival Rate; Thrombocytopenia

2017
Phase I study combining treatment with temsirolimus and sunitinib malate in patients with advanced renal cell carcinoma.
    Clinical genitourinary cancer, 2009, Volume: 7, Issue:1

    Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Cellulitis; Diarrhea; Drug Eruptions; Female; Humans; Indoles; Infusions, Intravenous; Kidney Neoplasms; Male; Middle Aged; Pyrroles; Sirolimus; Stomatitis; Sunitinib; Thrombocytopenia; Treatment Outcome

2009
Phase I trial of sunitinib malate plus interferon-alpha for patients with metastatic renal cell carcinoma.
    Clinical genitourinary cancer, 2009, Volume: 7, Issue:1

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Fatigue; Female; Humans; Indoles; Interferon-alpha; Kidney Neoplasms; Male; Middle Aged; Neutropenia; Pyrroles; Sunitinib; Thrombocytopenia; Treatment Outcome

2009
A phase II study of sunitinib in patients with recurrent and/or metastatic non-nasopharyngeal head and neck cancer.
    Cancer chemotherapy and pharmacology, 2010, Volume: 65, Issue:4

    Topics: Aged; Angiogenesis Inhibitors; Anorexia; Area Under Curve; Carcinoma, Squamous Cell; Drug Administration Schedule; Fatigue; Female; Head and Neck Neoplasms; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Indoles; Male; Metabolic Clearance Rate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Pyrroles; Sunitinib; Survival Analysis; Thrombocytopenia; Treatment Outcome; Vascular Endothelial Growth Factor A

2010
The efficacy and safety of sunitinib in korean patients with advanced renal cell carcinoma: high incidence of toxicity leads to frequent dose reduction.
    Japanese journal of clinical oncology, 2010, Volume: 40, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Anemia; Antineoplastic Agents; Asian People; Carcinoma, Renal Cell; Dose-Response Relationship, Drug; Fatigue; Female; Follow-Up Studies; Humans; Indoles; Kaplan-Meier Estimate; Kidney Neoplasms; Male; Middle Aged; Neoplasm Staging; Pyrroles; Republic of Korea; Sunitinib; Thrombocytopenia; Treatment Outcome

2010
Sunitinib in relapsed or refractory diffuse large B-cell lymphoma: a clinical and pharmacodynamic phase II multicenter study of the NCIC Clinical Trials Group.
    Leukemia & lymphoma, 2011, Volume: 52, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antineoplastic Agents; Female; Humans; Indoles; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neutropenia; Pyrroles; Receptors, Vascular Endothelial Growth Factor; Salvage Therapy; Sunitinib; Thrombocytopenia; Treatment Failure; Tumor Burden

2011
A phase II study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in relapsed small cell lung cancer.
    Lung cancer (Amsterdam, Netherlands), 2011, Volume: 74, Issue:3

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Disease Progression; Female; Humans; Indoles; Lung Neoplasms; Middle Aged; Proto-Oncogene Proteins c-bcl-2; Pyrroles; Recurrence; Thrombocytopenia; Topotecan

2011
Experience in the use of sunitinib given as a single agent in metastatic chemoresistant and castration-resistant prostate cancer patients.
    Expert opinion on pharmacotherapy, 2011, Volume: 12, Issue:16

    Topics: Adenocarcinoma; Aged; Aged, 80 and over; Anemia; Angiogenesis Inhibitors; Castration; Diarrhea; Drug Resistance, Neoplasm; Fatigue; Hand-Foot Syndrome; Humans; Indoles; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms; Pyrroles; Sunitinib; Thrombocytopenia; Treatment Outcome

2011
Sunitinib for Asian patients with advanced renal cell carcinoma: a comparable efficacy with different toxicity profiles.
    Oncology, 2011, Volume: 80, Issue:5-6

    Topics: Adult; Aged; Anemia; Antineoplastic Agents; Asian People; Carcinoma, Renal Cell; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Indoles; Kidney Neoplasms; Male; Middle Aged; Neutropenia; Nomograms; Predictive Value of Tests; Pyrroles; Republic of Korea; Risk Factors; Sunitinib; Thrombocytopenia; Treatment Outcome

2011
A phase I study of sunitinib combined with modified FOLFOX6 in patients with advanced solid tumors.
    Cancer chemotherapy and pharmacology, 2012, Volume: 70, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Dose-Response Relationship, Drug; Drug Administration Schedule; Fatigue; Female; Fluorouracil; Humans; Indoles; Leucovorin; Male; Metabolic Clearance Rate; Middle Aged; Neoplasms; Neutropenia; Organoplatinum Compounds; Oxaliplatin; Pyrroles; Sunitinib; Thrombocytopenia; Treatment Outcome

2012
Phase II open-label study of sunitinib in patients with advanced breast cancer.
    Breast cancer research and treatment, 2012, Volume: 136, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Breast Neoplasms; Diarrhea; Disease-Free Survival; Fatigue; Female; Humans; Indoles; Middle Aged; Nausea; Pyrroles; Sunitinib; Thrombocytopenia; Treatment Outcome

2012
A phase II study of sunitinib in patients with relapsed or refractory small cell lung cancer.
    Lung cancer (Amsterdam, Netherlands), 2013, Volume: 79, Issue:2

    Topics: Aged; Antineoplastic Agents; Asthenia; Disease-Free Survival; Female; Humans; Indoles; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Pyrroles; Small Cell Lung Carcinoma; Sunitinib; Thrombocytopenia; Treatment Outcome

2013
Fluorouracil, leucovorin, and irinotecan plus either sunitinib or placebo in metastatic colorectal cancer: a randomized, phase III trial.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, Apr-01, Volume: 31, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colorectal Neoplasms; Diarrhea; Double-Blind Method; Drug Administration Schedule; Fatigue; Female; Fluorouracil; Humans; Indoles; Irinotecan; Kaplan-Meier Estimate; Leucovorin; Male; Middle Aged; Neoplasm Metastasis; Neutropenia; Pyrroles; Sunitinib; Thrombocytopenia; Treatment Outcome

2013

Other Studies

20 other study(ies) available for pyrroles and Thrombopenia

ArticleYear
Development of severe thrombocytopenia with TAFRO syndrome-like features in a patient with rheumatoid arthritis treated with a Janus kinase inhibitor: A case report.
    Medicine, 2020, Oct-16, Volume: 99, Issue:42

    Topics: Aged; Arthritis, Rheumatoid; Castleman Disease; Fatal Outcome; Female; Humans; Janus Kinase Inhibitors; Multiple Organ Failure; Piperidines; Pyrimidines; Pyrroles; Thrombocytopenia

2020
Treatment Patterns and Burden of Illness in Patients Initiating Targeted Therapy or Chemotherapy for Pancreatic Neuroendocrine Tumors.
    Pancreas, 2017, Volume: 46, Issue:7

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Cost of Illness; Everolimus; Humans; Indoles; Middle Aged; Molecular Targeted Therapy; Nausea; Neuroendocrine Tumors; Pancreatic Neoplasms; Pyrroles; Retrospective Studies; Sunitinib; Thrombocytopenia; Vomiting; Young Adult

2017
Significance of Age in Japanese Patients Receiving Sunitinib as First-line Systemic Therapy for Metastatic Renal Cell Carcinoma: Comparative Assessment of Efficacy and Safety between Patients Aged <75 and ≥75 Years.
    Anticancer research, 2018, Volume: 38, Issue:6

    Topics: Aged; Aged, 80 and over; Aging; Antineoplastic Agents; Asian People; Carcinoma, Renal Cell; Disease-Free Survival; Fatigue; Female; Humans; Indoles; Japan; Kidney Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Pyrroles; Retrospective Studies; Sunitinib; Thrombocytopenia; Treatment Outcome

2018
[Comparison of efficacy between sorafenib and sunitinib as first-line therapy for metastatic renal cell carcinoma and analyze prognostic factors for survival].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2018, May-23, Volume: 40, Issue:5

    Topics: Antineoplastic Agents; Carcinoma, Renal Cell; Diarrhea; Disease Progression; Disease-Free Survival; Hand-Foot Syndrome; Humans; Indoles; Kidney Neoplasms; Multivariate Analysis; Neutropenia; Niacinamide; Phenylurea Compounds; Prognosis; Proportional Hazards Models; Pyrroles; Retrospective Studies; Risk Factors; Sorafenib; Sunitinib; Thrombocytopenia; Treatment Outcome

2018
Three cases of sporadic medullary thyroid carcinoma in progression treated with sunitinib.
    Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 2014, Volume: 61, Issue:1

    Topics: Aged; Antineoplastic Agents; Carcinoma, Medullary; Combined Modality Therapy; Hand-Foot Syndrome; Humans; Indoles; Liver Neoplasms; Male; Middle Aged; Neck Dissection; Neoplasms, Second Primary; Protein Kinase Inhibitors; Pyrroles; Sunitinib; Thrombocytopenia; Thyroid Neoplasms; Thyroidectomy

2014
Sunitinib-induced hypertension, neutropaenia and thrombocytopaenia as predictors of good prognosis in patients with metastatic renal cell carcinoma.
    BJU international, 2016, Volume: 117, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Biomarkers; Carcinoma, Renal Cell; Female; Humans; Hypertension; Indoles; Kaplan-Meier Estimate; Kidney Neoplasms; Male; Middle Aged; Neutropenia; Prognosis; Pyrroles; Retrospective Studies; Sunitinib; Thrombocytopenia; Treatment Outcome

2016
[Genetic polymorphisms of PDGFR associated with thrombocytopenia in Chinese patients with clear-cell metastatic renal cell carcinoma treated with sunitinib].
    Zhonghua yi xue za zhi, 2014, Oct-21, Volume: 94, Issue:38

    Topics: Antineoplastic Agents; Asian People; Carcinoma, Renal Cell; Genotype; Humans; Indoles; Polymorphism, Genetic; Pyrroles; Receptors, Platelet-Derived Growth Factor; Sunitinib; Thrombocytopenia; Treatment Outcome

2014
Pharmacokinetic-pharmacodynamic analysis of sunitinib-induced thrombocytopenia in Japanese patients with renal cell carcinoma.
    Biological & pharmaceutical bulletin, 2015, Volume: 38, Issue:3

    Topics: Aged; Antineoplastic Agents; Asian People; Blood Platelets; Carcinoma, Renal Cell; Drug Administration Schedule; Drug Dosage Calculations; Female; Humans; Indoles; Intestinal Absorption; Japan; Male; Middle Aged; Models, Biological; Platelet Count; Pyrroles; Sunitinib; Thrombocytopenia

2015
Association Study of a Functional Variant on ABCG2 Gene with Sunitinib-Induced Severe Adverse Drug Reaction.
    PloS one, 2016, Volume: 11, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Amino Acid Substitution; Antineoplastic Agents; Asian People; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Carcinoma, Renal Cell; Case-Control Studies; Female; Genetic Association Studies; Humans; Indoles; Japan; Kidney Neoplasms; Male; Middle Aged; Neoplasm Proteins; Polymorphism, Single Nucleotide; Pyrroles; Sunitinib; Thrombocytopenia

2016
[Successful Management by Immunoglobulin for Sunitinib-Induced Thrombocytopenia in a Patient with Advanced Metastatic Renal Cell Carcinoma].
    Hinyokika kiyo. Acta urologica Japonica, 2016, Volume: 62, Issue:2

    Topics: Aged, 80 and over; Antineoplastic Agents; Biopsy; Carcinoma, Renal Cell; Humans; Immunoglobulins; Indoles; Kidney Neoplasms; Male; Pyrroles; Sunitinib; Thrombocytopenia

2016
Retrospective evaluation of toceranib phosphate (Palladia®) toxicity in cats.
    Veterinary and comparative oncology, 2017, Volume: 15, Issue:3

    Topics: Alanine Transaminase; Animals; Antineoplastic Agents; Azotemia; Cat Diseases; Cats; Female; Gastrointestinal Tract; Indoles; Male; Neoplasms; Neutropenia; Pyrroles; Retrospective Studies; Thrombocytopenia

2017
Severe toxicity induced by accumulation of active sunitinib metabolite in a Japanese patient with renal cell carcinoma: a case report.
    Journal of medical case reports, 2017, Feb-01, Volume: 11, Issue:1

    Topics: Antineoplastic Agents; Asian People; Carcinoma, Renal Cell; Drug Administration Schedule; Humans; Indoles; Kidney Neoplasms; Male; Middle Aged; Pyrroles; Sunitinib; Thrombocytopenia; Treatment Outcome

2017
Treatment of hemodialyzed patient with sunitinib.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2009, Volume: 20, Issue:2

    Topics: Anemia; Antineoplastic Agents; Carcinoma, Renal Cell; Coronary Artery Bypass; Diarrhea; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Hypertension; Indoles; Male; Middle Aged; Nausea; Nephrectomy; Pyrroles; Remission Induction; Renal Dialysis; Sunitinib; Thrombocytopenia; Treatment Outcome; Vomiting

2009
Renal cell carcinoma: complete response.
    Anti-cancer drugs, 2010, Volume: 21 Suppl 1

    Topics: Carcinoma, Renal Cell; Humans; Indoles; Kidney Neoplasms; Lung Neoplasms; Male; Middle Aged; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrroles; Radiography; Smoking; Sunitinib; Thrombocytopenia; Treatment Outcome

2010
Myelosuppression by sunitinib is flt-3 genotype dependent.
    British journal of cancer, 2010, Aug-24, Volume: 103, Issue:5

    Topics: Antineoplastic Agents; fms-Like Tyrosine Kinase 3; Humans; Indoles; Leukopenia; Polymorphism, Genetic; Pyrroles; Sunitinib; Thrombocytopenia

2010
Efficacy of temsirolimus after previous treatment with sunitinib, sorafenib or everolimus in advanced renal cell cancer.
    Oncology, 2011, Volume: 80, Issue:1-2

    Topics: Aged; Aged, 80 and over; Anemia; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Carcinoma, Renal Cell; Diarrhea; Disease-Free Survival; Everolimus; Female; Humans; Indoles; Karnofsky Performance Status; Kidney Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Nausea; Neoplasm Metastasis; Niacinamide; Phenylurea Compounds; Pyridines; Pyrroles; Retrospective Studies; Sirolimus; Sorafenib; Sunitinib; Thrombocytopenia

2011
Efficacy and safety of vascular endothelial growth factor receptor tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma and poor risk features.
    Journal of cancer research and clinical oncology, 2012, Volume: 138, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Carcinoma, Renal Cell; Drug Administration Schedule; Fatigue; Female; Humans; Indazoles; Indoles; Kidney Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Niacinamide; Phenylurea Compounds; Prognosis; Protein Kinase Inhibitors; Pyridines; Pyrimidines; Pyrroles; Receptors, Vascular Endothelial Growth Factor; Retrospective Studies; Sorafenib; Sulfonamides; Sunitinib; Survival Analysis; Thrombocytopenia; Treatment Outcome; Young Adult

2012
Sunitinib-associated pseudothrombocytopenia induced by IgM antibody.
    Platelets, 2013, Volume: 24, Issue:7

    Topics: Humans; Immunoglobulin M; Indoles; Male; Middle Aged; Platelet Aggregation; Pyrroles; Sunitinib; Thrombocytopenia

2013
Tolmetin-induced thrombocytopenia.
    Arthritis and rheumatism, 1982, Volume: 25, Issue:9

    Topics: Child, Preschool; Female; Humans; Pyrroles; Thrombocytopenia; Tolmetin

1982
Atorvastatin-induced severe thrombocytopenia.
    Lancet (London, England), 1998, Oct-17, Volume: 352, Issue:9136

    Topics: Anticholesteremic Agents; Atorvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pyrroles; Thrombocytopenia

1998